DE68906707D1 - 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen. - Google Patents

3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen.

Info

Publication number
DE68906707D1
DE68906707D1 DE8989303050T DE68906707T DE68906707D1 DE 68906707 D1 DE68906707 D1 DE 68906707D1 DE 8989303050 T DE8989303050 T DE 8989303050T DE 68906707 T DE68906707 T DE 68906707T DE 68906707 D1 DE68906707 D1 DE 68906707D1
Authority
DE
Germany
Prior art keywords
substituted
oxindol
inhibit
cell activity
carboxamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989303050T
Other languages
English (en)
Other versions
DE68906707T2 (de
Inventor
Henry James Showell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE68906707D1 publication Critical patent/DE68906707D1/de
Application granted granted Critical
Publication of DE68906707T2 publication Critical patent/DE68906707T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE8989303050T 1988-04-13 1989-03-28 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen. Expired - Fee Related DE68906707T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (2)

Publication Number Publication Date
DE68906707D1 true DE68906707D1 (de) 1993-07-01
DE68906707T2 DE68906707T2 (de) 1993-09-16

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989303050T Expired - Fee Related DE68906707T2 (de) 1988-04-13 1989-03-28 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen.

Country Status (17)

Country Link
US (1) US4853409A (de)
EP (1) EP0337628B1 (de)
JP (1) JPH01311022A (de)
KR (1) KR920002328B1 (de)
AT (1) ATE89725T1 (de)
AU (1) AU601326B2 (de)
CA (1) CA1324762C (de)
DE (1) DE68906707T2 (de)
DK (1) DK174289A (de)
HU (1) HU204996B (de)
IE (1) IE62751B1 (de)
IL (1) IL89872A (de)
MY (1) MY103872A (de)
NZ (1) NZ228712A (de)
PH (1) PH25857A (de)
PT (1) PT90249B (de)
ZA (1) ZA892622B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE69413518T2 (de) * 1993-01-22 1999-02-11 Pfizer Lysin salz von 6-fluoro-3,2-(2-thenoyl)-2-oxidol-1-carboxamid
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
NZ286951A (en) * 1995-07-13 1998-02-26 Anormed Inc Substituted Under N-n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (de) * 1996-08-21 1998-03-04 Pfizer Inc. Stabile, lange aktive Salze von Carboxamiden für die Behandlung von Gelenkskrankheiten
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (de) * 2013-12-19 2015-06-24 Sanofi Oxindolderivate, ihre Herstellung und ihre therapeutische Verwendung zur Behandlung von durch AMPK vermittelten Erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
EP0284612B1 (de) * 1986-01-30 1991-07-24 University of Utah Behandlung von knochenschwund
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду

Also Published As

Publication number Publication date
IL89872A0 (en) 1989-12-15
ATE89725T1 (de) 1993-06-15
PT90249B (pt) 1994-06-30
PH25857A (en) 1991-12-02
HU204996B (en) 1992-03-30
NZ228712A (en) 1997-02-24
KR890015740A (ko) 1989-11-25
HUT52376A (en) 1990-07-28
ZA892622B (en) 1990-11-28
AU3271289A (en) 1989-10-19
EP0337628A2 (de) 1989-10-18
AU601326B2 (en) 1990-09-06
EP0337628B1 (de) 1993-05-26
IE891171L (en) 1989-10-13
MY103872A (en) 1993-09-30
DK174289A (da) 1989-10-16
IE62751B1 (en) 1995-02-22
CA1324762C (en) 1993-11-30
KR920002328B1 (ko) 1992-03-21
JPH01311022A (ja) 1989-12-15
PT90249A (pt) 1989-11-10
IL89872A (en) 1994-06-24
DE68906707T2 (de) 1993-09-16
DK174289D0 (da) 1989-04-12
EP0337628A3 (de) 1991-01-02
US4853409A (en) 1989-08-01

Similar Documents

Publication Publication Date Title
DE68906707T2 (de) 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen.
DK599789A (da) 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
DE68906706T2 (de) 3-substituierte 2-oxindol-1-carboxamid-derivate als hemmer der biosynthese des interleukins-1.
DE68912376T2 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
DK52685A (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
DK520787D0 (da) Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
NO872812L (no) 4-nitrogensubstituerte isokinolinolforbindelser med terapeutisk aktivitet og fremgangsmŸte for deres fremstilling.
DE3887426D1 (de) Eperisone als Hypotonikum.
ES2053808T3 (es) Nuevos compuestos azolicos.
DE3874978D1 (de) Ponalrestat enthaltendes hyperurikaemie-mittel.
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee